A Look at How Germany Structures Drug Purchasing

James Robinson in a recent perspective piece published in NEJM looks at how Germany purchases medicines.

Germany’s system, he writes, not only incentivizes agreements but also restricts price increases if there exists no evidence-based justification.

To read the write up, click here. (Paid subscription required)